No profile data available.
CareDx, Inc (CDNA) is a healthcare company in the DNA testing equipment industry, based in Brisbane, United States, with about 761 full-time employees.
It reported revenue of $379.81 million for fiscal year 2025, up 13.8% from fiscal year 2024, and net income of -$21.35 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $117.70 million, up 39.0% from a year before. United States was its largest region in fiscal year 2025, with 95% of revenue. Its market capitalization was $3.29 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CareDx reported $379.81 million in revenue for fiscal year 2025, up 13.8% from $333.79 million in fiscal year 2024. In Q1 2026 revenue was $117.70 million.
United States: 95% of revenue by region in fiscal year 2025, followed by Rest of World (5%).
$3.29 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include Grail, Inc. (GRAL), Adaptive Biotechnologies Corporation (ADPT), Veracyte, Inc. (VCYT), Castle Biosciences, Inc. (CSTL).